Source: 4-TRADERS

Reprogenetics: New Study Is First to Demonstrate Whole Genome Sequencing of Biopsied Embryos During In Vitro Fertilization (IVF) Can Detect De Novo Mutations Responsible for Most Genetic Diseases

(4-traders.com) LIVINGSTON, NJ--(Marketwired - Feb 12, 2015) - Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro...http://www.4-traders.com/news/New-Study-Is-First-to-Demonstrate-Whole-Genome-Sequencing-of-Biopsied-Embryos-During-In-Vitro-Fertil--19858332/

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more